Four-year data after pediatric renal transplantation: A randomized trial of tacrolimus vs. cyclosporin microemulsion

Pediatric Transplantation

Volumn 9, Issue 4, 2005, Pages 498-503

  Filler, Guido ^a   Webb, Nicholas J A ^a   Milford, David V ^a   Watson, Alan R ^a   Gellermann, Jutta ^a   Tyden, Gunnar ^a   Grenda, Ryszard ^a   Vondrak, Karel ^a   Hughes, David ^a   Offner, Gisela ^a   Griebel, Martin ^a   Brekke, Inge B ^a   McGraw, Mary ^a   Balzar, Egon ^a   Friman, Styrbjörn ^a   Trompeter, Richard ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Cyclosporin microemulsion; Glomerular filtration rate; Graft survival; Pediatric; Renal transplant; Surrogate marker; Tacrolimus

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CORTICOSTEROID; CYCLOSPORIN A; INSULIN; METHYLPREDNISOLONE; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; AORTA DISSECTION; ARTICLE; BRAIN HEMORRHAGE; CARDIOPULMONARY INSUFFICIENCY; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INTERSTITIAL PNEUMONIA; KAPLAN MEIER METHOD; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MICROEMULSION; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; NEPHROSCLEROSIS; NEPHROTOXICITY; PEDIATRIC SURGERY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; THROMBOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; AZATHIOPRINE; CHILD; CYCLOSPORINE; EMULSIONS; EUROPE; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 23844485530     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00334.x     Document Type: Article

References (18)

1. PIRSCH JD, MILLER J, DEIERHOI MH, VINCENTI F, FILO RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997: 63: 977-983.
2. MAYER AD, DMITREWSKI J, SQUIFFLET JP, BESSE T, GRABENSEE B, KLEIN B, et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 1997: 64: 436-443.
3. FILLER G. Evidence-based immunosuppression after pediatric renal transplantation-a dream? Transplant Proc 2003: 35: 2125-2127.
4. TROMPETER R, FILLER G, WEBB NJ, WATSON AR, MILFORD DV, TYDEN G, et al. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol 2002: 17: 141-149.
5. FILLER G, TROMPETER R, WEBB NJ, WATSON AR, MILFORD DV, TYDEN G, et al. One-year glomerular filtration rate predicts graft survival in pediatric renal recipients: a randomized trial of tacrolimus vs cyclosporine microemulsion. Transplant Proc 2002: 34: 1935-1938.
6. SMITH JM, MCDONALD RA. Progress in renal transplantation for children. Adv Ren Replace Ther 2000: 7: 158-171.
7. KNOLL GA, BELL RC. Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomised trials. BMJ 1999: 318: 1104-1107.
8. FILLER G, BROWNE R, SEIKALY MG. Glomerular nitration rate as a putative 'surrogate end-point' for renal transplant clinical trials in children. Pediatr Transplant 2003: 7: 18-24.
9. The European Agency for the Evaluation of Medicinal Products EMEA. Consolidated Guideline. 1.6.1996; CPMP/ICH/ 135/95. London, UK: ICH Technical Coordination.
10. SCHWARTZ GJ, HAYCOCK GB, EDELMANN CM Jr, SPITZER A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976: 58: 259-263.
11. BASADONNA GP, MATAS AJ, GILLINGHAM KJ, PAYNE WD, DUNN DL, SUTHERLAND DE, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993: 55: 993-995.
12. DE GRUTTOLA VG, CLAX P, DEMETS DL, et al. Considerations in the evaluation of surrogate endpoints in clinical trials. Summary of a National Institutes of Health workshop. Control Clin Trials 2001: 22: 485-502.
13. MATAS AJ, GILLINGHAM KJ, PAYNE WD, NAJARIAN JS. The impact of an acute rejection episode on long-term renal allograft survival (tl/2). Transplantation 1994: 57: 857-859.
14. DEL CASTILLO D. Analysis of primary and recurrent rejection following renal transplantation in a large, comparative, multicentre trial. Transplant Proc 2001: 33: 1259-1261.
15. SHAPIRO R, SCANTLEBURY VP, JORDAN ML, et al. Pediatric renal transplantation under tacrolimus-based immunosuppression. Transplantation 1999: 67: 299-303.
16. GOODMAN WG, GOLDIN J, KUIZON BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000: 18: 1478-1483.
17. VINCENTI F, JENSIK SC, FILO RS, MILLER J, PIRSCH J. A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. Transplantation 2002: 73: 775-782.
18. PAPE L, EHRICH JH, OFFNER G. Advantages of cyclosporin A using 2-h levels in pediatric kidney transplantation. Pediatr Nephrol 2004: 19: 1035-1038.